Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.37 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.37 |
| ▸ | FAAH | O00519 | 2/20 | 0.35 |
| ▸ | JAK3 | P52333 | 2/20 | 0.34 |
| ▸ | DDR1 | Q08345 | 3/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | CRHBP | P24387 | 1/20 | 0.33 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.33 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.33 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2356854 | 0.89 | TRPV1 (0.39) | TRPV1P2RX7FAAHDDR1KCNH2 | |
| SCHEMBL15468119 | 0.88 | TRPV1 (0.38) | TRPV1P2RX7FAAHDDR1KCNH2 | |
| SCHEMBL794782 | 0.87 | TRPV1 (0.37) | TRPV1P2RX7FAAHDDR1KCNH2 | |
| SCHEMBL798235 | 0.86 | EPHX2 (0.45) | P2RX7KCNH2EPHX2 | |
| SCHEMBL13219719 | 0.84 | EPHX2 (0.39) | TRPV1P2RX7FAAHDDR1KCNH2 | |
| SCHEMBL18250822 | 0.84 | TRPV1 (0.37) | TRPV1P2RX7FAAHDDR1KCNH2 | |
| SCHEMBL3129253 | 0.82 | DDR1 (0.40) | TRPV1P2RX7DDR1EPHX2NR1H4 | |
| SCHEMBL12467240 | 0.81 | FAAH (0.40) | TRPV1P2RX7FAAHENPP2EPHX2 | |
| SCHEMBL15467164 | 0.80 | EPHX2 (0.40) | TRPV1P2RX7FAAHDDR1ENPP2 | |
| SCHEMBL2306565 | 0.80 | FAAH (0.33) | FAAHAOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140294968-A1 | POLYACRYLATE-BASED ACTIVE COMPOUND-COMPRISING PARTICLES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-10-02 | — | — | US | disclosed |
| EP-2736326-A1 | POLYACRYLATE-BASED ACTIVE COMPOUND-COMPRISING PARTICLES | Bayer Intellectual Property GmbH (DE) | 2014-06-04 | — | — | EP | disclosed |
| CN-103702559-A | Polyacrylate-based active compound-comprising particles | BAYER IP GMBH | 2014-04-02 | — | — | CN | disclosed |
| WO-2013014127-A1 | POLYACRYLATE-BASED ACTIVE COMPOUND-COMPRISING PARTICLES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-01-31 | — | — | WO | disclosed |
| EP-2550863-A1 | Particles on a polyacrylate basis containing active materials | Bayer Intellectual Property GmbH (DE) | 2013-01-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140294968-A1 | POLYACRYLATE-BASED ACTIVE COMPOUND-COMPRISING PARTICLES | PLOD3, CUTA, NUP205 | TRPV1 37/4885P2RX7 1021/4885FAAH 2437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.